NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Blau Farmacêutica S.A (SA: BLAU3)
BLAU3 Technical Analysis
4
As on 21st Nov 2024 BLAU3 STOCK Price closed @ 15.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 15.37 & Strong Sell for SHORT-TERM with Stoploss of 19.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BLAU3STOCK Price
Open | 15.01 | Change | Price | % |
High | 15.02 | 1 Day | -0.09 | -0.60 |
Low | 14.53 | 1 Week | -0.21 | -1.38 |
Close | 15.02 | 1 Month | 1.81 | 13.70 |
Volume | 163900 | 1 Year | -4.99 | -24.94 |
52 Week High 21.55 | 52 Week Low 9.41 |
SA Brazil Most Active Stocks
IBOV | 107200.56 | -1.04% |
VIIA3 | 0.58 | -1.69% |
HAPV3 | 2.88 | -4.64% |
B3SA3 | 9.82 | -2.00% |
COGN3 | 1.32 | -3.65% |
CVCB3 | 2.40 | 1.27% |
VVAR3 | 8.14 | 1.75% |
ASAI3 | 6.94 | -0.43% |
BIDI11 | 10.06 | -4.64% |
BBAS3 | 25.26 | -2.28% |
SA Brazil Top Gainers Stocks
SA Brazil Top Losers Stocks
BLAU3 Daily Charts |
BLAU3 Intraday Charts |
Whats New @ Bazaartrend |
BLAU3 Free Analysis |
|
BLAU3 Important Levels Intraday
RESISTANCE | 15.96 |
RESISTANCE | 15.66 |
RESISTANCE | 15.47 |
RESISTANCE | 15.29 |
SUPPORT | 14.75 |
SUPPORT | 14.57 |
SUPPORT | 14.38 |
SUPPORT | 14.08 |
BLAU3 Forecast November 2024
4th UP Forecast | 23.48 |
3rd UP Forecast | 20.77 |
2nd UP Forecast | 19.09 |
1st UP Forecast | 17.41 |
1st DOWN Forecast | 12.63 |
2nd DOWN Forecast | 10.95 |
3rd DOWN Forecast | 9.27 |
4th DOWN Forecast | 6.56 |
BLAU3 Weekly Forecast
4th UP Forecast | 21.30 |
3rd UP Forecast | 19.29 |
2nd UP Forecast | 18.04 |
1st UP Forecast | 16.80 |
1st DOWN Forecast | 13.24 |
2nd DOWN Forecast | 12.00 |
3rd DOWN Forecast | 10.75 |
4th DOWN Forecast | 8.74 |
BLAU3 Forecast2024
4th UP Forecast | 39.86 |
3rd UP Forecast | 31.89 |
2nd UP Forecast | 26.97 |
1st UP Forecast | 22.05 |
1st DOWN Forecast | 7.99 |
2nd DOWN Forecast | 3.07 |
3rd DOWN Forecast | -1.85 |
4th DOWN Forecast | -9.82 |
Blau Farmacêutica S.A ( SA Brazil Symbol : BLAU3 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BLAU3 Other Details
Segment | EQ | |
Market Capital | 6558644736.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
BLAU3 Address
BLAU3 Latest News
BLAU3 Business Profile
Blau Farmacêutica S.A., a pharmaceutical company, engages in the production and sale of biological medications in the United States, Colombia, Chile, Peru, Argentina, Uruguay, and Brazil. The company's medications cover various therapeutic classes, such as oncology, hematology, nephrology, rheumatology, infectiology, anesthesiology, intensive care, general practice, and others. Its medications also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolíticos. The company was founded in 1987 and is headquartered in Cotia, Brazil. Address: Rodovia Raposo Tavares, 2833 km 30,5, Cotia, SP, Brazil, 06705-030
2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service